Ge Long Hui A P P·2025-12-22 11:53Group 1 - The core viewpoint of the news is that Baiyunshan (600332.SH) has approved a partnership to establish the Guangzhou Guangyao Guangkai Venture Capital Fund to expand investment scale, diversify investment risks, and enhance investment efficiency [1][2] - The Guangyao Guangkai Fund aims to have a target size of 300 million yuan, with an initial fundraising goal of 200 million yuan [1] - The Baiyao Phase II Fund will contribute 97.5 million yuan, accounting for 48.75% of the fund, while Guangyao Capital and Guangkai Fund will contribute 2.5 million yuan and 100 million yuan, accounting for 1.25% and 50.00% respectively [1] Group 2 - This investment aligns with the investment direction of the Baiyao Phase II Fund and is expected to strengthen the company's presence in innovative pharmaceuticals, modern traditional Chinese medicine, and high-end medical devices [2] - The strategy of "investing early, investing small, and investing in the future" aims to engage with quality enterprises at the source, fostering potential companies and accelerating technological upgrades and value chain extensions [2] - This initiative is part of the company's transition from a traditional business model to a technology-driven development model, laying a solid foundation for high-quality growth [2]